Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 13,079	$ 17,300
Less provision for bad debts of Healthcare Facilities Segment	33	716
Net revenues	13,046	16,584
Costs and Expenses
Cost of goods sold	4,636	4,597
Salaries, wages and benefits	5,845	8,317
Provision for bad debts of Specialty Pharmacy Segment	91	222
Supplies	436	916
Purchased services	708	869
Other operating expenses	1,710	2,201
Rent and lease expense	129	201
Depreciation and amortization	444	427
Operating Loss	(953)	(1,166)
Other Income, (Expense):
Gain on sale of assets	22	1
Gain on extinguishment of debt	46	0
Interest expense - net	(221)	(217)
Loss from Continuing Operations before income taxes	(1,106)	(1,382)
Income tax expense (benefit)	144	(249)
Loss from Continuing Operations	(1,250)	(1,133)
Earnings from Discontinued Operations, net of tax	4,273	(535)
Net Earnings (Loss)	3,023	(1,668)
Other comprehensive income	0	0
Comprehensive Earnings (Loss)	$ 3,023	$ (1,668)
Continuing Operations:
Basic	$ (0.13)	$ (0.12)
Diluted	(0.13)	(0.12)
Discontinued Operations:
Basic	0.45	(0.06)
Diluted	0.45	(0.06)
Net Earnings (Loss):
Basic	0.32	(0.18)
Diluted	$ 0.32	$ (0.18)
Weighted-Average Common Shares Outstanding:
Basic	9,443	9,443
Diluted	9,443	9,443